Sangamo Eliminating 27% of U.S. Workforce, Refocusing Pipeli

Sangamo Therapeutics will eliminate 27% of its U.S. workforce—some 120 jobs—and refocus its pipeline on three specialties.

Related Keywords

United States , France , Brisbane , Queensland , Australia , American , Sandy Macrae , R Andrew Ramelmeier , Phillip Ramsey , Los Angeles , Novartis Institutes For Biomedical Research , Novartis , American Society For Cell , American Society , Gene Therapy , Andrew Ramelmeier , Novartis Institutes , Biomedical Research ,